ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2016

Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approaches to Neuroblastoma Therapy) Trial.

Steven G DuBois et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.